{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:41:45Z","timestamp":1793407305024,"version":"4.5.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1098","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Graves\u2019 disease can be treated with antithyroid drugs (ATDs), radioiodine or surgery. Use of definitive treatments (radioiodine or surgery) varies widely across centres. Specific clinical circumstances, local facilities, patient and clinician preferences and perceptions will affect the choice of treatment. Detailed understanding of UK clinicians\u2019 views and their rationale for different treatments is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To study the preferences and perceptions of UK clinicians on the role of surgery and radioiodine in the management of Graves\u2019 disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>\u2018British Thyroid Association\u2019 (BTA), \u2018Society for Endocrinology\u2019 (SFE) and \u2018British Association of Endocrine and Thyroid Surgeons\u2019 (BAETS) members were invited to complete an online survey examining their management decisions in Graves\u2019 disease and factors that influenced their decisions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>158 responses from UK consultants were included. The ratio of physicians to surgeons was 11:5 and males to females was 12:4. Most clinicians would commence ATDs in uncomplicated first presentation of Graves\u2019 disease. A wide range of risk estimates on the effectiveness and risks of treatment was given by clinicians. Radioiodine was used most frequently in relapsed Graves\u2019 disease. However, severe eye disease and pregnancy strongly influenced choice in favour of surgery. Surgeons underestimated the success of radioiodine (p&amp;lt;0.01) and were more likely to recommend thyroidectomy than physicians.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This survey demonstrates significant variation in clinicians\u2019 perceptions of risks of treatment and their choice of management options for relapsed Graves\u2019 disease. The variation appeared to be dependent on patient and disease-specific factors as well as physician experience, gender and specialty.<\/jats:p><\/jats:sec>","DOI":"10.1136\/postgradmedj-2016-134187","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T02:29:55Z","timestamp":1471400995000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Variation in the use of definitive treatment options in the management of Graves\u2019 disease: a UK clinician survey"],"prefix":"10.1093","volume":"93","author":[{"given":"Jessica","family":"Hookham","sequence":"first","affiliation":[{"name":"Medical School, University of Sheffield , Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Allahabadia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabapathy P","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2265.1999.00629.x","article-title":"Antithyroid drugs and Graves\u2019 disease\u2014prospective randomized assessment of long-term treatment","volume":"50","author":"Maugendre","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1210\/jcem-70-3-675","article-title":"Antithyroid drugs and Graves\u2019 disease: a prospective randomized evaluation of the efficacy of treatment duration","volume":"70","author":"Allannic","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/pmj.76.896.340","article-title":"Trends in diagnostic and therapeutic criteria in Graves\u2019 disease in the last 10 years","volume":"76","author":"Escobar-Jim\u00e9nez","year":"2000","journal-title":"Postgrad Med J"},{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-2265.2007.03097.x","article-title":"Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists","volume":"68","author":"Vaidya","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"84","author":"Bartalena","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023041308185498000_","first-page":"3","article-title":"The management of hyperthyroidism due to Graves\u2019 disease in Europe in 1986. Results of an international survey","volume":"285","author":"Glinoer","year":"1987","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"2023041308185498000_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn Chair","year":"2011","journal-title":"Thyroid"},{"key":"2023041308185498000_","first-page":"CD003420","article-title":"Antithyroid drug regimen for treating Graves\u2019 hyperthyroidism","author":"Abraham","year":"2010","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/93\/1098\/198\/49840570\/postgradmedj-93-198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/93\/1098\/198\/49840570\/postgradmedj-93-198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T18:03:31Z","timestamp":1692468211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/93\/1098\/198\/6984358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":10,"journal-issue":{"issue":"1098","published-online":{"date-parts":[[2016,8,16]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2016-134187","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2017,4]]},"published":{"date-parts":[[2016,8,16]]}}}